Susquehanna International Group
ANTH

Susquehanna International Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Susquehanna International Group’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,525
Closed -$8K – 10627
2016
Q4 		$8K Sell
1,525
-5,125
-77% -$88.7K ﹤0.01% 9478
2016
Q3 		$168K Sell
6,650
-18,838
-74% -$475K ﹤0.01% 7707
2016
Q2 		$630K Buy
25,488
+23,025
+935% +$650K ﹤0.01% 5730
2016
Q1 		$71K Sell
2,463
-500
-17% -$13.6K ﹤0.01% 8567
2015
Q4 		$110K Sell
2,963
-3,437
-54% -$152K ﹤0.01% 8838
2015
Q3 		$312K Sell
6,400
-8,763
-58% -$612K ﹤0.01% 7981
2015
Q2 		$1.05M Buy
15,163
+7,175
+90% +$332K ﹤0.01% 6129
2015
Q1 		$286K Buy
7,988
+5,925
+287% +$175K ﹤0.01% 8055
2014
Q4 		$26K Sell
2,063
-4,200
-67% -$61K ﹤0.01% 9467
2014
Q3 		$96K Buy
6,263
+2,963
+90% +$62.3K ﹤0.01% 9090
2014
Q2 		$89K Buy
3,300
+1,475
+81% +$36.4K ﹤0.01% 9455
2014
Q1 		$49K Buy
+1,825
New +$46.3K ﹤0.01% 8712

Other funds holding ANTH

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Susquehanna International Group's ANTH Position: Q1 2018 in Review

Susquehanna International Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 784,744 shares — an estimated $1.17M sold.

Susquehanna International Group first reported a position in ANTH in Q4 2013 and held it in 15 quarters. The position peaked at $1.72M in Q2 2015. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

  • Susquehanna International Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 784,744 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.17M.
  • Susquehanna International Group first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2013 and held it in 15 quarters.
  • Susquehanna International Group's Anthera Pharmaceuticals, Inc. position peaked at $1.72M in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.